4DMedical (ASX:4DX) Change In Receivables : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 4DMedical Change In Receivables?

4DMedical's change in receivables for the quarter that ended in Dec. 2023 was A$0.00 Mil. It means 4DMedical's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

4DMedical's change in receivables for the fiscal year that ended in Jun. 2023 was A$0.00 Mil. It means 4DMedical's Accounts Receivable stayed the same from Jun. 2022 to Jun. 2023 .

4DMedical's Accounts Receivable for the quarter that ended in Dec. 2023 was A$1.02 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. 4DMedical's Days Sales Outstanding for the six months ended in Dec. 2023 was 234.97.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. 4DMedical's liquidation value for the six months ended in Dec. 2023 was A$-3.40 Mil.

4DMedical Change In Receivables Historical Data

The historical data trend for 4DMedical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical Change In Receivables Chart

4DMedical Annual Data

Trend

Jun21

Jun22

Jun23

Change In Receivables

4DMedical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

4DMedical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

4DMedical (ASX:4DX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

4DMedical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.021	/	0.793	*	91
=	234.97

2. In Ben Graham's calculation of liquidation value, 4DMedical's accounts receivable are only considered to be worth 75% of book value:

4DMedical's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	47.879	-	52.601	+	0.75 * 1.021	+	0.5 * 1.112
=	-3.40

4DMedical Change In Receivables Related Terms

Thank you for viewing the detailed overview of 4DMedical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

4DMedical (ASX:4DX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

FDMDF:USA

Address

700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053

Website

https://www.4dmedical.com

4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines